SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 11, 2019

Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 11, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002261

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-227772

Date
Feb. 11, 2019
Author
Title: Chief
Form
CORRESP
Company
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)

Letter

Hoth Therapeutics, Inc.

Rockefeller Plaza, Suite 1039

New York, New York 10020

February 11, 2019

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Effie Simpson

Doug Jones

Julie Griffith

Susan Block

Re: Hoth Therapeutics, Inc.

Registration Statement on Form S-1, as amended File No. 333-227772

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday February 13, 2019, or as soon thereafter as possible.

Please notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Thank you,

HOTH THERAPEUTICS, INC.

By: /s/ Robb Knie

Name: Robb Knie

Title: Chief Executive Officer

Show Raw Text
CORRESP
1
filename1.htm

Hoth
Therapeutics, Inc.

1
Rockefeller Plaza, Suite 1039

New
York, New York 10020

February
11, 2019

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

 Attention:  Effie
Simpson

                                                                                Doug
Jones

                                                                                Julie
Griffith

                                                                                Susan
                                         Block

 Re: Hoth
Therapeutics, Inc.

                                                                                Registration Statement on Form S-1, as amended
 File No. 333-227772

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday February 13, 2019, or as soon
thereafter as possible.

Please
notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon
as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Thank you,

    HOTH THERAPEUTICS, INC.

    By: /s/
                                         Robb Knie

    Name: Robb
                                         Knie

    Title: Chief
                                         Executive Officer